Recombinant growth hormone therapy in children with short stature in Abu Dhabi: a cross-sectional study of indications and treatment outcomes
Early diagnosis of the pathological cause, if any, of short stature in children can lead to prompt intervention with recombinant growth hormone (rGH) treatment, potentially allowing them to achieve their true genetic height potential. However, it is crucial to identify children most likely to benefi...
Saved in:
| Main Authors: | Sara Salem Al Jneibi, Fatima Taha, Marwa Hammouri, Zahraa Allami, Stefan Weber, Jamal Aljubeh, Sareea Al Remeithi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Pediatrics |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2025.1516967/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Global trends in recombinant human growth hormone for the treatment of idiopathic short stature: a bibliometric analysis
by: Rong Ouyang, et al.
Published: (2025-08-01) -
Monogenic causes of familial short stature
by: Lukas Plachy, et al.
Published: (2024-12-01) -
Preliminary Efficacy of Growth Hormone Therapy in Children With Congenital HeartDisease and Short Stature: A Six-case Report and Literature Review
by: YANG Xi, et al.
Published: (2025-05-01) -
The comparative accuracy of handprints and footprints for stature and sex determination
by: Sara Gamal Abbas, et al.
Published: (2025-06-01) -
Familial idiopathic short stature and beyond: a case-report of a novel heterozygous NPR2 mutation.
by: Ylenia Giorgianni, et al.
Published: (2024-07-01)